• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美托洛尔与地尔硫䓬治疗无症状性心肌缺血的疗效

Efficacy of metoprolol and diltiazem in treating silent myocardial ischemia.

作者信息

Portegies M C, Sijbring P, Göbel E J, Viersma J W, Lie K I

机构信息

Department of Cardiology, University Hospital Groningen, The Netherlands.

出版信息

Am J Cardiol. 1994 Dec 1;74(11):1095-8. doi: 10.1016/0002-9149(94)90458-8.

DOI:10.1016/0002-9149(94)90458-8
PMID:7977065
Abstract

Recent studies strongly support the prognostic importance of transient silent ischemia. Because patients with silent ischemia are at higher risk of a cardiac event, they are likely to benefit not only from control of symptoms, but also from treatment directed at prevention of ischemia. The efficacy of controlled-release metoprolol 200 mg once daily and diltiazem 60 mg 4 times daily was assessed in a randomized, double-blind, crossover study in 32 patients with proven coronary artery disease, predominantly asymptomatic myocardial ischemia, positive bicycle exercise test results, and > or = 5 minutes of asymptomatic ST-segment depression on a 24-hour screening ambulatory electrocardiogram (ECG). At the beginning and at the end of both 3-week treatment periods, an exercise test was performed and a 72-hour ambulatory ECG was recorded. Both active treatment periods were preceded by a 2-week placebo phase. Both treatments effectively reduced and postponed exercise-induced ST depression and reduced the total ischemic integral on the ambulatory ECG. Only metoprolol significantly reduced the mean number of ischemic episodes (54%, p = 0.0003, vs 31% for diltiazem, p = NS) and the mean duration of ischemia (51%, p = 0.012, vs 27% for diltiazem, p = NS) compared with baseline values. Metoprolol strongly blunted the morning and afternoon peak in the circadian distribution of ischemia, whereas diltiazem did not change the circadian distribution of ischemia at all.

摘要

近期研究有力地支持了短暂性无症状性心肌缺血在预后方面的重要性。由于无症状性心肌缺血患者发生心脏事件的风险更高,他们不仅可能从症状控制中获益,还可能从针对预防缺血的治疗中获益。在一项随机、双盲、交叉研究中,对32例经证实患有冠状动脉疾病、主要为无症状性心肌缺血、自行车运动试验结果阳性且24小时动态心电图(ECG)显示有≥5分钟无症状性ST段压低的患者,评估了每日一次200毫克控释美托洛尔和每日4次60毫克地尔硫䓬的疗效。在两个为期3周的治疗期开始和结束时,进行运动试验并记录72小时动态心电图。两个积极治疗期之前均有一个为期2周的安慰剂阶段。两种治疗均有效减轻并推迟了运动诱发的ST段压低,并降低了动态心电图上的总缺血积分。与基线值相比,只有美托洛尔显著减少了缺血发作的平均次数(54%,p = 0.0003,地尔硫䓬为31%,p = 无统计学意义)和缺血的平均持续时间(51%,p = 0.012,地尔硫䓬为27%,p = 无统计学意义)。美托洛尔强烈减弱了缺血昼夜分布中的上午和下午高峰,而地尔硫䓬根本没有改变缺血的昼夜分布。

相似文献

1
Efficacy of metoprolol and diltiazem in treating silent myocardial ischemia.美托洛尔与地尔硫䓬治疗无症状性心肌缺血的疗效
Am J Cardiol. 1994 Dec 1;74(11):1095-8. doi: 10.1016/0002-9149(94)90458-8.
2
Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).稳定型心绞痛患者抗缺血治疗对动态缺血、运动能力及心绞痛症状影响之间的不一致性。心绞痛与无症状性缺血研究组(ASIS)。
J Am Coll Cardiol. 1993 Jun;21(7):1605-11. doi: 10.1016/0735-1097(93)90375-b.
3
Usefulness of heart rate variability in predicting drug efficacy (metoprolol vs diltiazem) in patients with stable angina pectoris.心率变异性在预测稳定型心绞痛患者药物疗效(美托洛尔与地尔硫䓬对比)中的作用。
Am J Cardiol. 1995 Oct 15;76(11):759-63. doi: 10.1016/s0002-9149(99)80222-7.
4
Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.普萘洛尔、地尔硫䓬和硝苯地平治疗稳定型心绞痛患者动态心肌缺血的比较。对动态心肌缺血、运动能力和心绞痛症状的不同影响。动态心肌缺血研究组。
Circulation. 1990 Dec;82(6):1962-72. doi: 10.1161/01.cir.82.6.1962.
5
Effect of diltiazem on symptomatic and asymptomatic episodes of ST segment depression occurring during daily life and during exercise.地尔硫䓬对日常生活及运动期间发生的ST段压低的有症状和无症状发作的影响。
Circulation. 1991 Jul;84(1):15-22. doi: 10.1161/01.cir.84.1.15.
6
Silent ischemic interval on exercise test is a predictor of response to drug therapy: a randomized crossover trial of metoprolol versus diltiazem in stable angina.运动试验中的无症状缺血间期是药物治疗反应的预测指标:美托洛尔与地尔硫䓬治疗稳定型心绞痛的随机交叉试验
Clin Cardiol. 2001 Jan;24(1):45-9. doi: 10.1002/clc.4960240108.
7
Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.对于正在服用β受体阻滞剂或钙拮抗剂的患者,间歇性经皮给予硝酸盐并不能改善缺血情况:无硝酸盐期间反弹性缺血的潜在作用。
J Am Coll Cardiol. 1995 Feb;25(2):349-55. doi: 10.1016/0735-1097(94)00416-n.
8
Effect of diltiazem slow-release formulation on silent myocardial ischemia in stable coronary artery disease. The Canadian Multicenter Diltiazem Study Group.地尔硫䓬缓释制剂对稳定型冠状动脉疾病无症状心肌缺血的影响。加拿大多中心地尔硫䓬研究组。
Am J Cardiol. 1992 Mar 6;69(7):30B-35B. doi: 10.1016/0002-9149(92)91347-7.
9
Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris.硝苯地平胃肠道治疗系统与地尔硫䓬在稳定型心绞痛中加用β受体阻滞剂时的疗效比较
Am J Cardiol. 1993 Apr 15;71(11):887-92. doi: 10.1016/0002-9149(93)90901-n.
10
Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris.
J Cardiovasc Pharmacol. 1991;18 Suppl 9:S55-60.

引用本文的文献

1
Silent ischemic interval on exercise test is a predictor of response to drug therapy: a randomized crossover trial of metoprolol versus diltiazem in stable angina.运动试验中的无症状缺血间期是药物治疗反应的预测指标:美托洛尔与地尔硫䓬治疗稳定型心绞痛的随机交叉试验
Clin Cardiol. 2001 Jan;24(1):45-9. doi: 10.1002/clc.4960240108.
2
Usefulness of laboratory mental stress test in patients with stable coronary artery disease.实验室心理应激测试在稳定型冠状动脉疾病患者中的应用价值
Clin Cardiol. 1997 Apr;20(4):367-71. doi: 10.1002/clc.4960200413.